ANNUAL REPORT 2017 ZINZINO AB (PUBL)

Zinzino (publ) announces that the Annual Report for 2017 is now published in Swedish at the company’s website, www.zinzino.com. An English version will be published within 45 days.

Zinzino will hold the Annual General Meeting on Wednesday May 15th, 2018 at. 13:00 in the company’s premises at Hulda Lindgrens Gata 8 in Gothenburg. Registration will start at. 12:45.

For more information:
Dag Bergheim Pettersen, CEO Zinzino, Mobile: +47 (0) 93 22 57 00

Pictures for publication free of charge:
Marcus Tollbom, Mobile: +46 (0) 70 190 03 12

Certified Adviser: Erik Penser Bank Aktiebolag

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 13:00 the 24th of April, 2018.
   
  
Zinzino AB (publ.) is a direct sales company that operates throughout Europe and North America. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns the Norwegian company BioActie Foods AS and the research and production unit Faun Pharma AS. Zinzino has more than 120 employees and currently trades in 33 markets across Europe and North America. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, Oslo, and in Florida, USA. Zinzino is a public company and its shares are listed on Nasdaq First North. In 2016, Zinzino was recognized with the award ‘’Superföretag 2015’’ by Veckans Affärer and the ‘’Gazelle’’ award by Dagens Industri.

Tags:

About Us

Zinzino AB (publ.) is a direct sales company which operates through the EU, Norway, Iceland and in North America. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns Norwegian BioActive Foods AS and the research and production unit Faun Pharma AS. Zinzino has over 120 employees. The company has its registered office in Gothenburg, and offices in Helsinki, Riga, Oslo and in Florida, United States. Zinzino is a public limited company and its shares are listed on Nasdaq First North.